Respiratory News and Research

RSS

Study highlights healthcare barriers facing volunteer firefighters in Texas

In recent years, several organizations have recognized the firefighting profession's unique and substantial work-related health hazards, including cancers, heart disease, chronic respiratory illnesses and post-traumatic stress disorder (PTSD).

12 Nov 2026

Unusual allergy triggers cause anaphylaxis in children and teenagers

When people think about anaphylaxis, peanuts, shellfish, or even bee sting often come to mind. Three medically challenging cases presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting show that severe allergic reactions can come from far less obvious places: a fish ingredient hidden in an energy drink, a natural hair oil and a popular children's sensory toy.

12 Nov 2026

Your fitness may say less about cellular aging than you think

In a study of 84 middle-aged adults, researchers found that higher perceived stress and older age were associated with shorter telomeres, while physical fitness, body composition, and lifestyle habits showed no consistent independent associations. The findings suggest that telomere length may reflect psychosocial and health-related burden more closely than current physical performance, although the reported chronic disease association requires clarification because of an inconsistency in the paper's statistical coding.

12 Nov 2026

Simple outpatient scoring system cuts deaths among malnourished children

New research co-led by the Centre for Global Child Health at The Hospital for Sick Children (SickKids) suggests that a new tool for use in low-resource settings can save lives and reduce the need for hospital stays among children receiving outpatient treatment for malnutrition.

12 Nov 2026

Doctors share simple ways to avoid illness during holiday travel

Thanksgiving and the winter holidays bring with them some of the busiest travel days of the year, and while it's a festive time for families and other loved ones, it can also create problems for your health.

12 Nov 2026

Orexo and SVF Vaccines collaborate to explore AmorphOX® formulation of LNP-mRNA vaccines

Orexo AB and SVF Vaccines AB today announced a research collaboration to investigate whether Orexo’s proprietary powder-based drug delivery technology, AmorphOX®, can be used to develop stable powder-based formulations of lipid nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccines.

12 Nov 2026

Declining vaccination rates put U.S. measles elimination at risk

More than a quarter century after measles was declared eradicated in the United States, the country is at risk of losing that public health achievement.

11 Nov 2026

Exercise benefits people with chronic disease, but does the type matter?

A meta-analysis of 48 studies found that physical activity improved several chronic disease-related health indicators, particularly blood pressure, heart rate, and cardiorespiratory fitness, with significant benefits among people with hypertension and diabetes. Aerobic exercise had the strongest statistical evidence in the primary analysis, but no exercise type proved superior, and substantial variation between studies limited the certainty of the findings.

11 Nov 2026

Can psychedelics help treat cancer beyond easing end-of-life fear?

A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.

11 Nov 2026

Could a common diabetes drug help prevent long COVID?

Metformin use soon after COVID-19 infection is associated with a 53% reduction in long COVID or death risk, reinforcing previous clinical findings.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

UCLA study identifies lipid imbalance as pulmonary fibrosis trigger

A new UCLA Health study in mice has identified a new potential trigger for pulmonary fibrosis: lipid dysregulation (a fat imbalance) within alveolar macrophages.

9 Nov 2026

Australian-developed MND therapy advances to Phase 2 clinical trial

An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.

9 Nov 2026

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum's PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum's lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

From Qureight 9 Nov 2026

Study links everyday nanoplastics to severe lung inflammation risk

Everyday plastic products, including water bottles, disposable cups, and packaging, can break down over time into tiny fragments known as nanoplastics.

9 Nov 2026

Coffee, vegetables and exercise share a surprising connection in your gut

In a study of 6,803 Japanese adults, researchers identified two opposing gut microbiome patterns linking diet, physical activity, smoking, and alcohol consumption with general health and 15 chronic diseases. Health-oriented microbial patterns were associated with butyrate production and lower inflammation, while disease-oriented patterns were linked to inflammatory processes, with microbiome-based prediction scores showing potential for distinguishing health and disease across international populations.

8 Nov 2026